Evaluation of recurrent venous thromboembolism in patients with Factor v Leiden mutation in heterozygous form

Thrombosis Research

Volumn 130, Issue 3, 2012, Pages 467-471

  Sveinsdottir, Signy V ^a,b   Saemundsson, Ymir ^a,b   Isma, Nazim ^a,b   Gottsäter, Anders ^a,b   Svensson, Peter J ^a,b  

^a LUND UNIVERSITY   (Sweden)

^b LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

FV Leiden mutation; recurrence; Venous thromboembolism

Indexed keywords

BLOOD CLOTTING FACTOR 5 LEIDEN; PROTHROMBIN;

ADULT; ARTICLE; BLOOD SAMPLING; CLINICAL EVALUATION; CONTROLLED STUDY; FEMALE; FLV GENE; FOLLOW UP; GENE; GENE MUTATION; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RECURRENCE RISK; RECURRENT DISEASE; THROMBOPHILIA; VENOUS THROMBOEMBOLISM;

FACTOR V; FEMALE; GENETIC MARKERS; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INCIDENCE; LOSS OF HETEROZYGOSITY; MALE; MIDDLE AGED; MUTATION; POLYMORPHISM, SINGLE NUCLEOTIDE; RECURRENCE; RISK ASSESSMENT; SWEDEN; VENOUS THROMBOEMBOLISM;

EID: 84865240406     PISSN: 00493848     EISSN: 18792472     Source Type: Journal    
DOI: 10.1016/j.thromres.2012.03.020     Document Type: Article

References (36)

1. F.A. Anderson Jr., H.B. Wheeler, R.J. Goldberg, D.W. Hosmer, and A. Forcier The prevalence of risk factors for venous thromboembolism among hospital patients Arch Intern Med 152 1992 1660 1664
2. M. Nordstrom, B. Lindblad, D. Bergqvist, and T. Kjellstrom A prospective study of the incidence of deep-vein thrombosis within a defined urban population J Intern Med 232 1992 155 160
3. F.A. Anderson Jr., and F.A. Spencer Risk factors for venous thromboembolism Circulation 107 2003 I9 I16
4. J.A. Heit Venous thromboembolism: disease burden, outcomes and risk factors J Thromb Haemost 3 2005 1611 1617
5. F.R. Rosendaal Risk factors for venous thrombotic disease Thromb Haemost 82 1999 610 619
6. B. Dahlback Physiological anticoagulation. Resistance to activated protein C and venous thromboembolism J Clin Invest 94 1994 923 927
7. R.M. Bertina, B.P. Koeleman, T. Koster, F.R. Rosendaal, R.J. Dirven, and H. de Ronde Mutation in blood coagulation factor V associated with resistance to activated protein C Nature 369 1994 64 67
8. F.R. Rosendaal, C.J. Doggen, A. Zivelin, V.R. Arruda, M. Aiach, and D.S. Siscovick Geographic distribution of the 20210 G to A prothrombin variant Thromb Haemost 79 1998 706 708
9. A. Hillarp, B. Zoller, P.J. Svensson, and B. Dahlback The 20210 A allele of the prothrombin gene is a common risk factor among Swedish outpatients with verified deep venous thrombosis Thromb Haemost 78 1997 990 992
10. C. Leroyer, B. Mercier, E. Oger, E. Chenu, J.F. Abgrall, and C. Ferec 20210 A allele of the prothrombin gene in venous thromboembolism patients Thromb Haemost 80 1998 49 51
11. U. Kjellberg, M. van Rooijen, K. Bremme, and M. Hellgren Factor V Leiden mutation and pregnancy-related complications Am J Obstet Gynecol 203 469 2010 e1 e8
12. F.R. Rosendaal, T. Koster, J.P. Vandenbroucke, and P.H. Reitsma High risk of thrombosis in patients homozygous for factor V Leiden (activated protein C resistance) Blood 85 1995 1504 1508
13. P. Prandoni, A.W. Lensing, A. Cogo, S. Cuppini, S. Villalta, and M. Carta The long-term clinical course of acute deep venous thrombosis Ann Intern Med 125 1996 1 7
14. P. Simioni, P. Prandoni, A.W. Lensing, D. Manfrin, D. Tormene, and S. Gavasso Risk for subsequent venous thromboembolic complications in carriers of the prothrombin or the factor V gene mutation with a first episode of deep-vein thrombosis Blood 96 2000 3329 3333
15. P.M. Ridker, J.P. Miletich, M.J. Stampfer, S.Z. Goldhaber, K. Lindpaintner, and C.H. Hennekens Factor V Leiden and risks of recurrent idiopathic venous thromboembolism Circulation 92 1995 2800 2802
16. S. Eichinger, E. Minar, M. Hirschl, C. Bialonczyk, M. Stain, and C. Mannhalter The risk of early recurrent venous thromboembolism after oral anticoagulant therapy in patients with the G20210A transition in the prothrombin gene Thromb Haemost 81 1999 14 17
17. C. Rintelen, I. Pabinger, P. Knobl, K. Lechner, and C. Mannhalter Probability of recurrence of thrombosis in patients with and without factor V Leiden Thromb Haemost 75 1996 229 232
18. V. De Stefano, I. Martinelli, P.M. Mannucci, K. Paciaroni, P. Chiusolo, and I. Casorelli The risk of recurrent deep venous thrombosis among heterozygous carriers of both factor V Leiden and the G20210A prothrombin mutation N Engl J Med 341 1999 801 806
19. M. Kovac, D. Mikovic, N. Antonijevic, L. Rakicevic, V. Djordjevic, and D. Radojkovic FV Leiden mutation and risk of recurrent venous thromboembolism in Serbian population J Thromb Thrombolysis 25 2008 284 287
20. W.K. Ho, G.J. Hankey, D.J. Quinlan, and J.W. Eikelboom Risk of recurrent venous thromboembolism in patients with common thrombophilia: a systematic review Arch Intern Med 166 2006 729 736
21. A. Marchiori, L. Mosena, M.H. Prins, and P. Prandoni The risk of recurrent venous thromboembolism among heterozygous carriers of factor V Leiden or prothrombin G20210A mutation. A systematic review of prospective studies Haematologica 92 2007 1107 1114
22. P. Simioni, P. Prandoni, A.W. Lensing, A. Scudeller, C. Sardella, and M.H. Prins The risk of recurrent venous thromboembolism in patients with an Arg506->Gln mutation in the gene for factor V (factor V Leiden) N Engl J Med 336 1997 399 403
23. M. Margaglione, G. D'Andrea, D. Colaizzo, G. Capicci, A. del Popolo, and V. Brancaccio Coexistence of factor V Leiden and Factor II A20210 mutations and recurrent venous thromboembolism Thromb Haemost 82 1999 1583 1587
24. P. Lindmarker, S. Schulman, M. Sten-Linder, B. Wiman, N. Egberg, and H. Johnsson The risk of recurrent venous thromboembolism in carriers and non-carriers of the G1691A allele in the coagulation factor V gene and the G20210A allele in the prothrombin gene. DURAC Trial Study Group. Duration of Anticoagulation Thromb Haemost 81 1999 684 689
25. P. Prandoni, F. Noventa, A. Ghirarduzzi, V. Pengo, E. Bernardi, and R. Pesavento The risk of recurrent venous thromboembolism after discontinuing anticoagulation in patients with acute proximal deep vein thrombosis or pulmonary embolism. A prospective cohort study in 1,626 patients Haematologica 92 2007 199 205
26. M.G. Santamaria, G. Agnelli, M.R. Taliani, P. Prandoni, M. Moia, and M. Bazzan Thrombophilic abnormalities and recurrence of venous thromboembolism in patients treated with standardized anticoagulant treatment Thromb Res 116 2005 301 306
27. V. De Stefano, P. Simioni, E. Rossi, D. Tormene, T. Za, and A. Pagnan The risk of recurrent venous thromboembolism in patients with inherited deficiency of natural anticoagulants antithrombin, protein C and protein S Haematologica 91 2006 695 698
28. J.A. Heit The epidemiology of venous thromboembolism in the community: implications for prevention and management J Thromb Thrombolysis 21 2006 23 29
29. A.G. van den Belt, B.J. Sanson, P. Simioni, P. Prandoni, H.R. Buller, and A. Girolami Recurrence of venous thromboembolism in patients with familial thrombophilia Arch Intern Med 157 1997 2227 2232
30. N. Isma, P.J. Svensson, A. Gottsater, and B. Lindblad Prospective analysis of risk factors and distribution of venous thromboembolism in the population-based Malmo Thrombophilia Study (MATS) Thromb Res 124 2009 663 666
31. J. Emmerich, M. Alhenc-Gelas, M.F. Aillaud, I. Juhan-Vague, B. Jude, and J.M. Garcin Clinical features in 36 patients homozygous for the ARG 506->GLN factor V mutation Thromb Haemost 77 1997 620 623
32. S. Eichinger, I. Pabinger, A. Stumpflen, M. Hirschl, C. Bialonczyk, and B. Schneider The risk of recurrent venous thromboembolism in patients with and without factor V Leiden Thromb Haemost 77 1997 624 628
33. P.J. Svensson, and B. Dahlback Resistance to activated protein C as a basis for venous thrombosis N Engl J Med 330 1994 517 522
34. S.C. Christiansen, S.C. Cannegieter, T. Koster, J.P. Vandenbroucke, and F.R. Rosendaal Thrombophilia, clinical factors, and recurrent venous thrombotic events JAMA 293 2005 2352 2361
35. J. Douketis, A. Tosetto, M. Marcucci, T. Baglin, B. Cosmi, and M. Cushman Risk of recurrence after venous thromboembolism in men and women: patient level meta-analysis BMJ 342 2011 d813
36. G. Palareti, C. Legnani, B. Cosmi, L. Valdre, B. Lunghi, and F. Bernardi Predictive value of D-dimer test for recurrent venous thromboembolism after anticoagulation withdrawal in subjects with a previous idiopathic event and in carriers of congenital thrombophilia Circulation 108 2003 313 318